Navigation Links
Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
Date:2/4/2013

er therapy. Research in oral mucositis management has focused on topical anti-infectives (defensins), growth factors and cytokines (KGFs and IL-11), cytoprotective agents (benzydamine, amifostine), and low level lasers therapy. Additional research interests include basic research and management strategies for other oral complications of cancer therapy including salivary gland dysfunction, oral graft-versus-host disease in allogeneic hematopoietic cell transplant recipients, and dental growth and development problems following hematopoietic cell transplant. Additionally, Dr. Schubert has been involved with research related to oral changes and infections in HIV-infected patients.  Dr. Schubert received his Doctor of Dental Surgery from the University of Washington, where he completed a residency in Hospital Dentistry, and later received his Masters of Dental Sciences degree from the University of Washington.

About SGX942

SGX94 is an IDR, a new class of short, synthetic peptides that has a novel mechanism of action in that it has simultaneous anti-inflammatory and anti-infective activity. IDRs have no direct antibiotic activity but modulate host responses, increasing survival after infections with a broad range of bacterial Gram-negative and Gram-positive pathogens, as well as accelerating resolution of tissue damage following exposure to a variety of agents including bacterial pathogens, trauma and chemo- and/or radiation-therapy.  SGX94 has demonstrated safety in a Phase 1 clinical study in healthy human volunteers and efficacy in numerous animal disease models including mucositis, colitis, skin infection and other bacterial infections.  SGX94 is the subject of an open Investigational New Drug (IND). SGX94 was developed pursuant to discoveries made by Professors B. Brett Finlay , PhD and Robert Hancock , PhD of the University of British Columbia, Canada and approximately $40 mill
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
2. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
3. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
4. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
5. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
6. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
7. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
11. Misonix Announces New Distribution Agreement For Panama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... A new poll finds little support for privatizing ... insurance program for older Americans needs major changes if ... Recently Medicare,s trustees indicated that funding to ... an estimated 45 million Americans 65 and older, could ...
... June 13, 2011 Enox Biopharma, Inc., a leader ... with medical devices, today announced that it has received ... application entitled "Device and Method for Administering Therapeutic Agents" ... Enox acquired this patent from its ...
Cached Medicine Technology:Little Support for GOP Plan to Privatize Medicare: Poll 2Little Support for GOP Plan to Privatize Medicare: Poll 3Little Support for GOP Plan to Privatize Medicare: Poll 4Little Support for GOP Plan to Privatize Medicare: Poll 5Little Support for GOP Plan to Privatize Medicare: Poll 6Little Support for GOP Plan to Privatize Medicare: Poll 7Enox Biopharma, Inc. Will Be Granted a Patent for the Delivery of Therapeutic Agents From Within Medical Devices 2
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... 2013) The American Gastroenterological Association (AGA) Research ... scholars. This year,s honorees are outstanding young gastroenterologists ... related areas, and with this award, their research ... researchers are the future of our field. AGA ... paving the way for promising research developments and ...
(Date:5/18/2013)... Thompson HealthDay Reporter , , FRIDAY, May 17 ... the latest edition of what is considered the "bible" ... many changes continues. "This is unprecedented, the amount ... Lieberman, president-elect of the American Psychiatric Association (APA). "It,s ... it is. You have to evaluate it and then ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) The use ... for a colonoscopy, according to new research presented ... process, which begins days in advance of the ... preparation medication to be taken at strict intervals. ... for doctors to see cancer and precancerous polyps ...
(Date:5/18/2013)... 18, 2013 Assisted living and ... to safety and comfort of their residents. Systems ... clients with an effective and cost-efficient solution – ... an integrated, turnkey communications solution that helps nurses ... residents independence and privacy. , The VisionLink ...
Breaking Medicine News(10 mins):Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:New smartphone application improves colonoscopy preparation 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3
... Association (APHA) today released its annual congressional record,which measures ... to public health., APHA,s report was compiled by ... votes during the first session of the 110th,Congress in ... senators voted in support of APHA,s,position on all eight ...
... Texas, (Feb. 1, 2008) - Amgen (NASDAQ: AMGN) and ... announced findings from a retrospective analysis, which demonstrated that ... in patients with moderate to severe plaque psoriasis following ... levels was 10 times greater in the ENBREL treated ...
... Concerns Raised Over DM&E,s Continued Pursuit of Powder River Expansion ... Despite CP,s ... today,asked the U.S. Surface Transportation Board (STB) to require mitigation ... Pacific,s pending,acquisition of the Dakota, Minnesota & Eastern Railroad (DM&E). ...
... SPRING, Md., Feb. 1 The Clinton,Campaign today ... The ANA represents the interests of the nation,s ... do without high quality health care, and this,country ... reform a,priority," said ANA President Rebecca M. Patton, ...
... offered to encourage healthy hearts, GLEN BURNIE, Md., ... Washington Medical Center has the key,to a healthier heart: ... medical center will host the fourth annual Day of ... a.m. to 3 p.m. at the Severna Park,Community Center ...
... WASHINGTON, Feb. 1 The U.S. Department of,Labor,s ... new National Emphasis Program (NEP) to target worksites ... (http://www.osha.gov/ )., "Exposure to silica threatens nearly ... Labor for OSHA Edwin G. Foulke, Jr.,"Under this ...
Cached Medicine News:Health News:APHA Scores Members of Congress on Public Health Voting Record 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 3Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 4Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 5Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 2Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 3Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 4Health News:The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY) 2Health News:Baltimore Washington Medical Center Hosts Day of Dance for Health 2Health News:OSHA Establishes a New National Emphasis Program on Silica 2
... System is a fully automated, upgradable platform ... blood parameters in addition to comprehensive on-board ... basic blood gas model to be quickly ... and CO-oximetry in a single unit. This ...
Microcomputer controlled, preparative ultracentrifuge, with CFC-free refrigeration system. Available either internally cooled or with external water cooling. Quikset user interface, Softspin automati...
... SE Micro-ultra centrifuge continues to raise the ... now with 1,048,000 x g performance and ... DiscoveryTMM150SE processes sample sizes from 0.2 ml ... footprint, brushless direct drive, very quiet operation, ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
Medicine Products: